BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8437851)

  • 1. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
    Cheng JT; Hsu HL; Hwang LY; Baer R
    Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
    Wadman IA; Hsu HL; Cobb MH; Baer R
    Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen.
    Hwang LY; Siegelman M; Davis L; Oppenheimer-Marks N; Baer R
    Oncogene; 1993 Nov; 8(11):3043-6. PubMed ID: 8414504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.
    Cheng JT; Cobb MH; Baer R
    Mol Cell Biol; 1993 Feb; 13(2):801-8. PubMed ID: 8423803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.
    Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
    Cancer Res; 2005 Jun; 65(11):4515-9. PubMed ID: 15930267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
    Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
    Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiapoptotic effect of ectopic TAL1/SCL expression in a human leukemic T-cell line.
    Bernard M; Delabesse E; Novault S; Hermine O; Macintyre EA
    Cancer Res; 1998 Jun; 58(12):2680-7. PubMed ID: 9635597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
    Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
    Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tal1 transgenic expression reveals absence of B lymphocytes.
    Palamarchuk A; Zanesi N; Aqeilan RI; Efanov A; Maximov V; Santanam U; Hagan JP; Croce CM; Pekarsky Y
    Cancer Res; 2006 Jun; 66(12):6014-7. PubMed ID: 16778172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L; Begley CG
    Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
    Hsu HL; Wadman I; Baer R
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
    Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
    Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study.
    Bash RO; Crist WM; Shuster JJ; Link MP; Amylon M; Pullen J; Carroll AJ; Buchanan GR; Smith RG; Baer R
    Blood; 1993 Apr; 81(8):2110-7. PubMed ID: 8471769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
    Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical study of TAL-1 protein expression in leukaemias and lymphomas with a novel monoclonal antibody, 2TL 242.
    Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K; Mason D
    J Pathol; 1996 Mar; 178(3):311-5. PubMed ID: 8778337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.